These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33847212)

  • 1. Single Subcutaneous Ketamine Dose Followed by Oral Ketamine for Depression Symptoms in Hospice Patients: A Case Series.
    Latuga NM; Luczkiewicz DL; Grant PC; Levy K; Hansen E; Kerr CW
    J Pain Palliat Care Pharmacother; 2021 Jun; 35(2):106-112. PubMed ID: 33847212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial.
    Irwin SA; Iglewicz A; Nelesen RA; Lo JY; Carr CH; Romero SD; Lloyd LS
    J Palliat Med; 2013 Aug; 16(8):958-65. PubMed ID: 23805864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Ketamine for Depression, 1: Pharmacologic Considerations and Clinical Evidence.
    Andrade C
    J Clin Psychiatry; 2019 Apr; 80(2):. PubMed ID: 30946543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compounded oral ketamine.
    McNulty JP; Hahn K
    Int J Pharm Compd; 2012; 16(5):364-8. PubMed ID: 23072195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Ketamine for Depression, 2: Practical Considerations.
    Andrade C
    J Clin Psychiatry; 2019 Apr; 80(2):. PubMed ID: 30997961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial.
    Jafarinia M; Afarideh M; Tafakhori A; Arbabi M; Ghajar A; Noorbala AA; Saravi MA; Agah E; Akhondzadeh S
    J Affect Disord; 2016 Nov; 204():1-8. PubMed ID: 27317968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ketamine for the treatment of pain and treatment-resistant depression†.
    Schoevers RA; Chaves TV; Balukova SM; aan het Rot M; Kortekaas R
    Br J Psychiatry; 2016 Feb; 208(2):108-13. PubMed ID: 26834167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care.
    Irwin SA; Iglewicz A
    J Palliat Med; 2010 Jul; 13(7):903-8. PubMed ID: 20636166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?
    Andrade C
    J Clin Psychiatry; 2017 Jul; 78(7):e852-e857. PubMed ID: 28749092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent subcutaneous furosemide: parenteral diuretic rescue for hospice patients with congestive heart failure resistant to oral diuretic.
    Farless LB; Steil N; Williams BR; Bailey FA
    Am J Hosp Palliat Care; 2013 Dec; 30(8):791-2. PubMed ID: 23136114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases.
    Iglewicz A; Morrison K; Nelesen RA; Zhan T; Iglewicz B; Fairman N; Hirst JM; Irwin SA
    Psychosomatics; 2015; 56(4):329-37. PubMed ID: 25616995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy of Ketamine in the Palliative Care Setting: A Comprehensive Review of the Literature.
    Goldman N; Frankenthaler M; Klepacz L
    J Palliat Med; 2019 Sep; 22(9):1154-1161. PubMed ID: 31090477
    [No Abstract]   [Full Text] [Related]  

  • 13. Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.
    Katalinic N; Lai R; Somogyi A; Mitchell PB; Glue P; Loo CK
    Aust N Z J Psychiatry; 2013 Aug; 47(8):710-27. PubMed ID: 23661785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated subcutaneous esketamine administration for depressive symptoms and pain relief in a terminally ill cancer patient: A case report.
    Barbosa MG; Delfino RS; Sarin LM; Jackowski AP
    Palliat Med; 2020 Jun; 34(6):822-825. PubMed ID: 32186250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid antidepressant effect of S-ketamine in schizophrenia.
    Bartova L; Papageorgiou K; Milenkovic I; Dold M; Weidenauer A; Willeit M; Winkler D; Kasper S
    Eur Neuropsychopharmacol; 2018 Aug; 28(8):980-982. PubMed ID: 30041987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine for depression clinical issues.
    Iqbal SZ; Mathew SJ
    Adv Pharmacol; 2020; 89():131-162. PubMed ID: 32616205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine in depression and electroconvulsive therapy.
    Rozet I
    Curr Opin Anaesthesiol; 2021 Oct; 34(5):556-562. PubMed ID: 34435599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Ketamine for Depression: A Systematic Review.
    Rosenblat JD; Carvalho AF; Li M; Lee Y; Subramanieapillai M; McIntyre RS
    J Clin Psychiatry; 2019 Apr; 80(3):. PubMed ID: 30995364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
    Koike H; Iijima M; Chaki S
    Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term ketamine administration in treatment-resistant depression: focus on cardiovascular safety.
    Szarmach J; Cubała WJ; Włodarczyk A; Wiglusz MS
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):585-590. PubMed ID: 31488795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.